Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions.
about
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population-PREDICTORS 4A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening resultsClinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.HPV Genotyping of Modified General Primer-Amplicons Is More Analytically Sensitive and Specific by Sequencing than by Hybridization.Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, ChinaA cohort study of cervical screening using partial HPV typing and cytology triage.Expanded strain coverage for a highly successful public health tool: prophylactic 9-valent human papillomavirus vaccine.Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing.Gardasil 9 joins the fight against cervix cancer.Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.Carcinogenic human papillomavirus infection.Need for expanded HPV genotyping for cervical screening.HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.
P2860
Q30239987-7CCBF981-3BC1-47CF-B109-FC5008834855Q30276176-7B6F5E28-6747-4957-A038-45B7E7534B80Q34916671-749558E4-5E63-4296-AD0A-C5A120B66DA8Q35036033-6CD1A185-D10B-4A28-9C7C-DD8FC6913F6EQ36238070-EB8C71C6-BEA8-41AA-B079-D2EA679DF7C8Q36675963-E2677B94-B3B5-455D-B30B-DCD5D37FE6C5Q37204991-573C87D4-9044-4063-B49C-F74592B69554Q38378838-1038A2B8-3846-4FF7-8ABE-EA587F9783F1Q38682763-788398B0-48B0-4994-9F03-DF08E99848FFQ38706590-D0D54772-4810-4011-B4B4-707465E93AEDQ41193779-A8D539B6-E662-4B65-B5F0-D12D1C8835FFQ41284477-375A8A70-0172-46E4-8104-55FCA76CDAB3Q44863515-1E7A7988-E25C-462F-BFE8-19CD745BAA01Q47599152-373E7137-5C4B-4663-AA3C-56C806B6283AQ49907625-4E5DEBCC-B934-435E-AF24-C9FC083A4C5F
P2860
Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Individual detection of 14 hig ...... f high grade cervical lesions.
@ast
Individual detection of 14 hig ...... f high grade cervical lesions.
@en
Individual detection of 14 hig ...... f high grade cervical lesions.
@nl
type
label
Individual detection of 14 hig ...... f high grade cervical lesions.
@ast
Individual detection of 14 hig ...... f high grade cervical lesions.
@en
Individual detection of 14 hig ...... f high grade cervical lesions.
@nl
prefLabel
Individual detection of 14 hig ...... f high grade cervical lesions.
@ast
Individual detection of 14 hig ...... f high grade cervical lesions.
@en
Individual detection of 14 hig ...... f high grade cervical lesions.
@nl
P2093
P2860
P1476
Individual detection of 14 hig ...... f high grade cervical lesions.
@en
P2093
George Terry
Jack Cuzick
Lesley Ashdown-Barr
Louise Cadman
Maria J Costa
Michael Giddings
Michelle Kleeman
P2860
P356
10.1016/J.JCV.2014.02.002
P577
2014-02-14T00:00:00Z